This NGS-based panel analyzes multiple genes associated with corneal dystrophies, a group of inherited conditions that cause progressive changes in corneal clarity and vision. Metropolis Healthcare uses high-depth sequencing to identify pathogenic variants responsible for different dystrophy subtypes, helping clinicians distinguish between similar ocular conditions. The test supports accurate diagnosis, guides management decisions, and assists in genetic counseling. A blood sample collected in an EDTA vial is required for analysis.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0184
Frequently Asked Questions (FAQ's):
What does the Corneal Dystrophy Gene Panel include at Metropolis Healthcare?
It includes targeted sequencing of genes known to cause various hereditary corneal dystrophies.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses advanced Next-Generation Sequencing with detailed bioinformatic analysis to detect clinically relevant variants.
Who should consider taking this test at Metropolis Healthcare?
Individuals with unexplained corneal opacities, recurrent erosions, or a family history of corneal dystrophy may benefit.
What type of sample is required for this panel at Metropolis Healthcare?
A blood sample collected in an EDTA tube is needed for sequencing.
How can this test help in clinical management?
It confirms the genetic subtype, helps predict disease progression, and supports treatment planning.
How long does Metropolis Healthcare take to provide the results?
Results are typically available within 2–4 weeks depending on sequencing complexity.
Can this test detect carriers of corneal dystrophy–related mutations?
Yes, the panel can identify carriers, which is valuable for family risk assessment.
Is genetic counseling recommended after this test at Metropolis Healthcare?
Yes, counseling helps interpret results and understand inheritance patterns and prognosis